Iron Horse Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.27K | Hold |
157
| – | – | ﹤0.01% | 328 |
|
|
2025
Q1 | $9.58K | Hold |
157
| – | – | ﹤0.01% | 279 |
|
|
2024
Q4 | $8.88K | Buy |
157
+9
| +6% | +$509 | ﹤0.01% | 252 |
|
|
2024
Q3 | $7.66K | Buy |
148
+35
| +31% | +$1.81K | ﹤0.01% | 262 |
|
|
2024
Q2 | $4.69K | Hold |
113
| – | – | ﹤0.01% | 284 |
|
|
2024
Q1 | $6.13K | Buy |
113
+35
| +45% | +$1.9K | ﹤0.01% | 238 |
|
|
2023
Q4 | $4K | Hold |
78
| – | – | ﹤0.01% | 289 |
|
|
2023
Q3 | $4.53K | Buy |
78
+37
| +90% | +$2.15K | ﹤0.01% | 277 |
|
|
2023
Q2 | $2.62K | Sell |
41
-30
| -42% | -$1.92K | ﹤0.01% | 208 |
|
|
2023
Q1 | $4.92K | Buy |
71
+30
| +73% | +$2.08K | ﹤0.01% | 204 |
|
|
2022
Q4 | $3K | Buy |
41
+15
| +58% | +$1.1K | ﹤0.01% | 174 |
|
|
2022
Q3 | $2K | Sell |
26
-15
| -37% | -$1.15K | ﹤0.01% | 111 |
|
|
2022
Q2 | $3K | Hold |
41
| – | – | ﹤0.01% | 169 |
|
|
2022
Q1 | $3K | Hold |
41
| – | – | ﹤0.01% | 178 |
|
|
2021
Q4 | $3K | Buy |
41
+15
| +58% | +$1.1K | ﹤0.01% | 159 |
|
|
2021
Q3 | $2K | Hold |
26
| – | – | ﹤0.01% | 152 |
|
|
2021
Q2 | $2K | Hold |
26
| – | – | ﹤0.01% | 155 |
|
|
2021
Q1 | $2K | Hold |
26
| – | – | ﹤0.01% | 145 |
|
|
2020
Q4 | $2K | Buy |
+26
| New | +$2K | ﹤0.01% | 144 |
|